[
  {
    "ts": null,
    "headline": "Mckesson lifts annual profit forecast on robust demand for specialty drugs",
    "summary": "U.S. drug distributor McKesson raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, banking on robust demand for specialty medicines. High profit margins for specialty medicines, which treat complex conditions such as rheumatoid arthritis and cancer, have encouraged companies to expand in the market. Texas-headquartered Mckesson expects per-share profit in the range of $37.10 to $37.90 for fiscal 2026, compared to its previous expectation of $36.90 to $37.70.",
    "url": "https://finnhub.io/api/news?id=d5fb696b7a32cdb3b9613fd6fb744b1ede9da7fbc7c1a6e5482f9df8bc68f27f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754515586,
      "headline": "Mckesson lifts annual profit forecast on robust demand for specialty drugs",
      "id": 136246466,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "U.S. drug distributor McKesson raised its annual profit forecast and beat Wall Street earnings estimates on Wednesday, banking on robust demand for specialty medicines. High profit margins for specialty medicines, which treat complex conditions such as rheumatoid arthritis and cancer, have encouraged companies to expand in the market. Texas-headquartered Mckesson expects per-share profit in the range of $37.10 to $37.90 for fiscal 2026, compared to its previous expectation of $36.90 to $37.70.",
      "url": "https://finnhub.io/api/news?id=d5fb696b7a32cdb3b9613fd6fb744b1ede9da7fbc7c1a6e5482f9df8bc68f27f"
    }
  },
  {
    "ts": null,
    "headline": "Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook",
    "summary": "Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion. Sales increased due to an 8.5% increase in revenue within the U.S. Healthcare Solutions segment and a 10.5% increase in revenue within the International Healthcare Solutions segment. “Cencora delivered strong financial results in the third fiscal quarter, driven by our pharmaceutical-centric strategy and focus on our growth priorities,” said Robert M",
    "url": "https://finnhub.io/api/news?id=12dff355e43d19fad7902b997c9d7c30c777b825171db6e674f1fe423a7df837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754500434,
      "headline": "Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook",
      "id": 136239229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion. Sales increased due to an 8.5% increase in revenue within the U.S. Healthcare Solutions segment and a 10.5% increase in revenue within the International Healthcare Solutions segment. “Cencora delivered strong financial results in the third fiscal quarter, driven by our pharmaceutical-centric strategy and focus on our growth priorities,” said Robert M",
      "url": "https://finnhub.io/api/news?id=12dff355e43d19fad7902b997c9d7c30c777b825171db6e674f1fe423a7df837"
    }
  },
  {
    "ts": null,
    "headline": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=8eb1d6d3c0016cb1b75424ece93b4f45973e4e30f60a275776faa41c8ad28f4a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498820,
      "headline": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
      "id": 136256569,
      "image": "",
      "related": "COR",
      "source": "MarketWatch",
      "summary": "Cencora Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=8eb1d6d3c0016cb1b75424ece93b4f45973e4e30f60a275776faa41c8ad28f4a"
    }
  },
  {
    "ts": null,
    "headline": "COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised",
    "summary": "Cencora posts strong Q3 results with earnings and revenues surpassing estimates; raises FY25 EPS guidance on robust U.S. segment growth.",
    "url": "https://finnhub.io/api/news?id=727c553ca570de12528e547014d2a723f083d2d282cc6a302c9fce03a0024621",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754490480,
      "headline": "COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised",
      "id": 136239131,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Cencora posts strong Q3 results with earnings and revenues surpassing estimates; raises FY25 EPS guidance on robust U.S. segment growth.",
      "url": "https://finnhub.io/api/news?id=727c553ca570de12528e547014d2a723f083d2d282cc6a302c9fce03a0024621"
    }
  },
  {
    "ts": null,
    "headline": "Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
    "url": "https://finnhub.io/api/news?id=1715e95a3df2c2690ad48b83ce03d06eca1d130da9dfee3878d5e12ef87f1b48",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754487004,
      "headline": "Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 136237446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.",
      "url": "https://finnhub.io/api/news?id=1715e95a3df2c2690ad48b83ce03d06eca1d130da9dfee3878d5e12ef87f1b48"
    }
  },
  {
    "ts": null,
    "headline": "CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View",
    "summary": "Charles River shares jump 9.3% pre-market after Q2 earnings and revenues beat estimates. The company raises its 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=b4409c4a7afb9624671795188dc21c6e238e3f8ed9725be14ba36b65f984f1da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754486640,
      "headline": "CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View",
      "id": 136237333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Charles River shares jump 9.3% pre-market after Q2 earnings and revenues beat estimates. The company raises its 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=b4409c4a7afb9624671795188dc21c6e238e3f8ed9725be14ba36b65f984f1da"
    }
  },
  {
    "ts": null,
    "headline": "Cencora, Inc. 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Cencora, Inc.",
    "url": "https://finnhub.io/api/news?id=96e475e2eb87f8d6b249521fa021750e3a4f5f4167a734351f16ecf14002c312",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754483245,
      "headline": "Cencora, Inc. 2025 Q3 - Results - Earnings Call Presentation",
      "id": 136238476,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "COR",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Cencora, Inc.",
      "url": "https://finnhub.io/api/news?id=96e475e2eb87f8d6b249521fa021750e3a4f5f4167a734351f16ecf14002c312"
    }
  },
  {
    "ts": null,
    "headline": "Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript",
    "summary": "Cencora, Inc. (NYSE:COR) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ETCompany ParticipantsBennett S.",
    "url": "https://finnhub.io/api/news?id=b40e6a7e7bcb470749eeba8591fc8d5b260a18c4913388e5e9317fa55a6c8649",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754483126,
      "headline": "Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript",
      "id": 136238478,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "COR",
      "source": "SeekingAlpha",
      "summary": "Cencora, Inc. (NYSE:COR) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ETCompany ParticipantsBennett S.",
      "url": "https://finnhub.io/api/news?id=b40e6a7e7bcb470749eeba8591fc8d5b260a18c4913388e5e9317fa55a6c8649"
    }
  },
  {
    "ts": null,
    "headline": "Cencora raises annual profit forecast on strong demand for specialty drugs",
    "summary": "U.S. drug distributor Cencora raised its annual profit forecast on Wednesday after posting quarterly earnings that topped Wall Street estimates, buoyed by surging demand for specialty therapies and blockbuster weight-loss drugs. The Philadelphia-based company now expects its annual adjusted profit between $15.85 and $16.00 per share, up from its previous expectation of $15.70 to $15.95 per share. Analysts, had expected a profit of $15.83 per share, according to LSEG data.",
    "url": "https://finnhub.io/api/news?id=ff5bf19131b041f7aca240876bcaed3203ec9e9d7d20a8dee36ac3a465e2dbcd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754481057,
      "headline": "Cencora raises annual profit forecast on strong demand for specialty drugs",
      "id": 136232439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "U.S. drug distributor Cencora raised its annual profit forecast on Wednesday after posting quarterly earnings that topped Wall Street estimates, buoyed by surging demand for specialty therapies and blockbuster weight-loss drugs. The Philadelphia-based company now expects its annual adjusted profit between $15.85 and $16.00 per share, up from its previous expectation of $15.70 to $15.95 per share. Analysts, had expected a profit of $15.83 per share, according to LSEG data.",
      "url": "https://finnhub.io/api/news?id=ff5bf19131b041f7aca240876bcaed3203ec9e9d7d20a8dee36ac3a465e2dbcd"
    }
  },
  {
    "ts": null,
    "headline": "Cencora (COR) Q3 Earnings and Revenues Surpass Estimates",
    "summary": "Cencora (COR) delivered earnings and revenue surprises of +5.82% and +0.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=c1ddd834c2aa403eb25ae7ef16551ee001aaea56fb70635576d0272a837f2b36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754480402,
      "headline": "Cencora (COR) Q3 Earnings and Revenues Surpass Estimates",
      "id": 136237449,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Cencora (COR) delivered earnings and revenue surprises of +5.82% and +0.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=c1ddd834c2aa403eb25ae7ef16551ee001aaea56fb70635576d0272a837f2b36"
    }
  },
  {
    "ts": null,
    "headline": "Cencora’s (NYSE:COR) Q2 Sales Top Estimates",
    "summary": "Healthcare distributor Cencora (NYSE:COR) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=796f50d12f98615dca0b3191782c8fd71126ae9f615af4c54f19cd27b2700e67",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754477298,
      "headline": "Cencora’s (NYSE:COR) Q2 Sales Top Estimates",
      "id": 136232524,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Healthcare distributor Cencora (NYSE:COR) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=796f50d12f98615dca0b3191782c8fd71126ae9f615af4c54f19cd27b2700e67"
    }
  },
  {
    "ts": null,
    "headline": "Cencora: Fiscal Q3 Earnings Snapshot",
    "summary": "CONSHOHOCKEN, Pa. AP) — Cencora, Inc. COR) on Wednesday reported fiscal third-quarter earnings of $687.4 million.",
    "url": "https://finnhub.io/api/news?id=8f6bc549e277a7610efae03f1f0b933a2596e20757c1959451ff4399827a9d1b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754477098,
      "headline": "Cencora: Fiscal Q3 Earnings Snapshot",
      "id": 136232525,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "CONSHOHOCKEN, Pa. AP) — Cencora, Inc. COR) on Wednesday reported fiscal third-quarter earnings of $687.4 million.",
      "url": "https://finnhub.io/api/news?id=8f6bc549e277a7610efae03f1f0b933a2596e20757c1959451ff4399827a9d1b"
    }
  },
  {
    "ts": null,
    "headline": "Cencora Reports Fiscal 2025 Third Quarter Results",
    "summary": "CONSHOHOCKEN, Pa., August 06, 2025--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year to $80.7 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.52 for the third quarter of fiscal 2025 compared to $2.42 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, incr",
    "url": "https://finnhub.io/api/news?id=ad176852fe58232b7961db4c4be95eed08f6e50a0bd32dc77180556b914bdb4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754476200,
      "headline": "Cencora Reports Fiscal 2025 Third Quarter Results",
      "id": 136232526,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "CONSHOHOCKEN, Pa., August 06, 2025--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year to $80.7 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.52 for the third quarter of fiscal 2025 compared to $2.42 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, incr",
      "url": "https://finnhub.io/api/news?id=ad176852fe58232b7961db4c4be95eed08f6e50a0bd32dc77180556b914bdb4a"
    }
  },
  {
    "ts": null,
    "headline": "Podcasting Impact: Unprecedented Press Coverage of All Three National Drug Wholesaler Conferences Supporting Independent Pharmacy",
    "summary": "First podcast dedicated to the profession of pharmacy covers McKesson, Cencora, and Cardinal Health events BROWNSVILLE PA / ACCESS Newswire / August 6, 2025 / RxPR, LLC is proud to announce that the Pharmacy Podcast Network (PPN) has successfully ...",
    "url": "https://finnhub.io/api/news?id=0f32522b4758f0660febeb3b930675a5790c220caaf8ba2b247f311ec3fd3b27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754470800,
      "headline": "Podcasting Impact: Unprecedented Press Coverage of All Three National Drug Wholesaler Conferences Supporting Independent Pharmacy",
      "id": 136232440,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "First podcast dedicated to the profession of pharmacy covers McKesson, Cencora, and Cardinal Health events BROWNSVILLE PA / ACCESS Newswire / August 6, 2025 / RxPR, LLC is proud to announce that the Pharmacy Podcast Network (PPN) has successfully ...",
      "url": "https://finnhub.io/api/news?id=0f32522b4758f0660febeb3b930675a5790c220caaf8ba2b247f311ec3fd3b27"
    }
  }
]